{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:11:50Z","timestamp":1792685510927,"version":"4.5.0"},"reference-count":79,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.biopha.2025.118944","type":"journal-article","created":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T06:34:21Z","timestamp":1767681261000},"page":"118944","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Advances in the use of MT1-MMP-targeted nanobodies and peptides for therapeutic delivery in triple-negative breast cancer"],"prefix":"10.1016","volume":"194","author":[{"given":"Parisa","family":"Shahmoradipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahman","family":"Emamzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118944_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118944_bib2","first-page":"524","article-title":"Breast cancer statistics, 2022","volume":"72","author":"Giaquinto","year":"2022","journal-title":"Ca. Cancer J. Clin."},{"key":"10.1016\/j.biopha.2025.118944_bib3","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1016\/S0140-6736(20)32381-3","article-title":"Breast cancer","volume":"397","author":"Loibl","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2025.118944_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10549-013-2461-x","article-title":"The prognostic impact of age in patients with triple-negative breast cancer","volume":"138","author":"Liedtke","year":"2013","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2025.118944_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13578-025-01359-0","article-title":"Classifications of triple-negative breast cancer: insights and current therapeutic approaches","volume":"15","author":"Chen","year":"2025","journal-title":"Cell Biosci."},{"key":"10.1016\/j.biopha.2025.118944_bib6","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2025.118944_bib7","article-title":"Breast cancer: pathogenesis and treatments","volume":"10","author":"Xiong","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2025.118944_bib8","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1200\/JOP.2017.023333","article-title":"Triple-negative breast cancer: current practice and future directions","volume":"13","author":"Costa","year":"2017","journal-title":"J. Oncol. Pr."},{"key":"10.1016\/j.biopha.2025.118944_bib9","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.55324\/josr.v2i5.845","article-title":"Incidence rate and clinical characteristics of triple negative breast cancer patients in Hasan Sadikin Hospital, for the last five years","volume":"2","author":"Gaol","year":"2023","journal-title":"J. Soc. Res."},{"key":"10.1016\/j.biopha.2025.118944_bib10","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1245\/s10434-016-5631-3","article-title":"Evaluation of local and distant recurrence patterns in patients with triple-negative breast cancer according to age","volume":"24","author":"Radosa","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.biopha.2025.118944_bib11","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","article-title":"Structure and function of matrix metalloproteinases and TIMPs","volume":"69","author":"Nagase","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.biopha.2025.118944_bib12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13048-021-00852-7","article-title":"The role of MMP-14 in ovarian cancer: a systematic review","volume":"14","author":"Vos","year":"2021","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.biopha.2025.118944_bib13","article-title":"Potential target within the tumor microenvironment-MT1-MMP","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118944_bib14","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1083\/jcb.149.6.1309","article-title":"Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3","volume":"149","author":"Hotary","year":"2000","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(02)00699-7","article-title":"Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion","volume":"194","author":"Seiki","year":"2003","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118944_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1108695","article-title":"Matrix metalloproteinases as therapeutic targets in breast cancer","volume":"12","author":"Kwon","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.biopha.2025.118944_bib17","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-11-4149","article-title":"Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth","volume":"72","author":"Remacle","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118944_bib18","doi-asserted-by":"crossref","first-page":"33167","DOI":"10.1074\/jbc.M111.256644","article-title":"Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration","volume":"286","author":"Zarrabi","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib19","doi-asserted-by":"crossref","first-page":"10195","DOI":"10.1074\/jbc.M112.447169","article-title":"Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis","volume":"288","author":"Ingvarsen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2013.44","article-title":"A monoclonal antibody interferes with TIMP-2 binding and incapacitates the MMP-2-activating function of multifunctional, pro-tumorigenic MMP-14\/MT1\u2013MMP","volume":"2","author":"Shiryaev","year":"2013","journal-title":"Oncogenesis"},{"key":"10.1016\/j.biopha.2025.118944_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1058455","article-title":"Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging","volume":"9","author":"Mulero","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2025.118944_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrc1075","article-title":"Tumour-cell invasion and migration: diversity and escape mechanisms","volume":"3","author":"Friedl","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118944_bib23","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1083\/jcb.201210152","article-title":"Physical limits of cell migration: control by ECM space and nuclear deformation and tuning by proteolysis and traction force","volume":"201","author":"Wolf","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib24","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1349-7006.2005.00039.x","article-title":"Roles of membrane-type matrix metalloproteinase-1 in tumor invasion and metastasis","volume":"96","author":"Sato","year":"2005","journal-title":"Cancer Sci."},{"key":"10.1016\/j.biopha.2025.118944_bib26","doi-asserted-by":"crossref","first-page":"R692","DOI":"10.1016\/S0960-9822(00)00720-X","article-title":"Matrix metalloproteinases","volume":"10","author":"Matrisian","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceb.2023.102309","article-title":"Extracellular matrix dynamics: a key regulator of cell migration across length-scales and systems","volume":"86","author":"Pally","year":"2024","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/iub.2672","article-title":"Extracellular matrix: the dynamic structural and functional network in health and disease","volume":"74","author":"Karamanos","year":"2022","journal-title":"IUBMB Life"},{"key":"10.1016\/j.biopha.2025.118944_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/wnan.1503","article-title":"Extracellular matrix remodeling in 3D: implications in tissue homeostasis and disease progression","volume":"10","author":"Ford","year":"2018","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2025.118944_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/JMAU.JMAU_4_18","article-title":"Extracellular matrix remodeling in human disease","volume":"6","author":"Sonbol","year":"2018","journal-title":"J. Microsc. Ultra"},{"key":"10.1016\/j.biopha.2025.118944_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97597","article-title":"\u03b1v\u03b23 Integrin drives fibroblast contraction and strain stiffening of soft provisional matrix during progressive fibrosis","volume":"3","author":"Fiore","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118944_bib32","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg3840","article-title":"The extracellular matrix as hallmark of cancer and metastasis: from biomechanics to therapeutic targets","volume":"16","author":"Sleeboom","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biopha.2025.118944_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib34","first-page":"1","article-title":"Substrate modulation of osteoblast adhesion strength, focal adhesion kinase activation, and responsiveness to mechanical stimuli","volume":"3","author":"Takai","year":"2006","journal-title":"Mol. Cell. Biomech."},{"key":"10.1016\/j.biopha.2025.118944_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108609","article-title":"Mechanical stiffness controls dendritic cell metabolism and function","volume":"34","author":"Chakraborty","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2025.118944_bib36","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3390\/cells13050438","article-title":"Exploring extracellular matrix crosslinking as a therapeutic approach to fibrosis","volume":"13","author":"Lloyd","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2025.118944_bib37","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ncb3157","article-title":"Matrix stiffness drives epithelial\u2013mesenchymal transition and tumour metastasis through a TWIST1\u2013G3BP2 mechanotransduction pathway","volume":"17","author":"Wei","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107285","article-title":"The role of matrix metalloproteinase-9 in cardiac remodeling and dysfunction and as a possible blood biomarker in heart failure","volume":"206","author":"Rodrigues","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.biopha.2025.118944_bib39","article-title":"The role of membrane-Type 1 matrix metalloproteinase\u2013substrate interactions in pathogenesis","volume":"24","author":"Lee","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118944_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.3390\/cancers6010416","article-title":"Monitoring and inhibiting MT1-MMP during cancer initiation and progression","volume":"6","author":"Pahwa","year":"2014","journal-title":"Cancers"},{"key":"10.1016\/j.biopha.2025.118944_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70281","article-title":"Extracellular matrix signaling cues: biological functions, diseases, and therapeutic targets","volume":"6","author":"Zhao","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.biopha.2025.118944_bib42","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14728222.2022.2170779","article-title":"The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting","volume":"26","author":"Furukawa","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.biopha.2025.118944_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","article-title":"Biochemical and biological attributes of matrix metalloproteinases","volume":"147","author":"Cui","year":"2017","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.biopha.2025.118944_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1124\/pharmrev.121.000349","article-title":"Matrix metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology","volume":"74","author":"de Almeida","year":"2022","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.biopha.2025.118944_bib45","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/370061a0","article-title":"A matrix metalloproteinase expressed on the surface of invasive tumour cells","volume":"370","author":"Sato","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118944_bib46","doi-asserted-by":"crossref","first-page":"5068","DOI":"10.3390\/ijms24065068","article-title":"Cytoplasmic tail of MT1-MMP: a hub of MT1-MMP regulation and function","volume":"24","author":"Strouhalova","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118944_bib47","doi-asserted-by":"crossref","first-page":"E1872","DOI":"10.1073\/pnas.1400749111","article-title":"Control of MT1-MMP transport by atypical PKC during breast-cancer progression","volume":"111","author":"Ross\u00e9","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118944_bib48","first-page":"583","article-title":"Expression of membrane type-1 matrix metalloproteinase, MT1-MMP in human breast cancer and its impact on invasiveness of breast cancer cells","volume":"17","author":"Jiang","year":"2006","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.biopha.2025.118944_bib49","doi-asserted-by":"crossref","first-page":"4527","DOI":"10.1158\/0008-5472.CAN-10-4376","article-title":"Cancer cell\u2013associated MT1-MMP promotes blood vessel invasion and distant metastasis in triple-negative mammary tumors","volume":"71","author":"Perentes","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.biopha.2025.118944_bib50","first-page":"120","article-title":"The overexpression membrane type 1 matrix metalloproteinase is associated with the progression and prognosis in breast cancer","volume":"7","author":"Li","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.biopha.2025.118944_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/emboj\/20.17.4782","article-title":"M. Seiki, Homophilic complex formation of MT1-MMP facilitates proMMP-2 activation on the cell surface and promotes tumor cell invasion","author":"Itoh","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.biopha.2025.118944_bib52","doi-asserted-by":"crossref","first-page":"13053","DOI":"10.1074\/jbc.M709327200","article-title":"The second dimer interface of MT1-MMP, the transmembrane domain, is essential for ProMMP-2 activation on the cell surface","volume":"283","author":"Itoh","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.canlet.2018.11.031","article-title":"The membrane tethered matrix metalloproteinase MT1-MMP triggers an outside-in DNA damage response that impacts chemo-and radiotherapy responses of breast cancer","volume":"443","author":"Thakur","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biopha.2025.118944_bib54","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.153.5.893","article-title":"Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration","volume":"153","author":"Kajita","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib55","doi-asserted-by":"crossref","first-page":"29951","DOI":"10.1074\/jbc.M110.132704","article-title":"A membrane protease regulates energy production in macrophages by activating hypoxia-inducible factor-1 via a non-proteolytic mechanism","volume":"285","author":"Sakamoto","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib56","doi-asserted-by":"crossref","first-page":"30350","DOI":"10.1074\/jbc.M109.019216","article-title":"Mint3 enhances the activity of hypoxia-inducible factor-1 (HIF-1) in macrophages by suppressing the activity of factor inhibiting HIF-1","volume":"284","author":"Sakamoto","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.1016\/j.biopha.2025.118944_bib58","doi-asserted-by":"crossref","first-page":"7848","DOI":"10.1021\/ja070870h","article-title":"Inhibitor fingerprinting of matrix metalloproteases using a combinatorial peptide hydroxamate library","volume":"129","author":"Uttamchandani","year":"2007","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2025.118944_bib59","doi-asserted-by":"crossref","first-page":"10000","DOI":"10.1073\/pnas.0402784101","article-title":"Activity-based probes for the proteomic profiling of metalloproteases","volume":"101","author":"Saghatelian","year":"2004","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118944_bib60","doi-asserted-by":"crossref","first-page":"6653","DOI":"10.1021\/jm100669j","article-title":"Orally active MMP-1 sparing \u03b1-tetrahydropyranyl and \u03b1-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease","volume":"53","author":"Becker","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib61","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.03.015","article-title":"Matrix metalloproteinases: regulators of the tumor microenvironment","volume":"141","author":"Kessenbrock","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.biopha.2025.118944_bib62","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1038\/sj.onc.1204097","article-title":"Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment","volume":"19","author":"Zucker","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.biopha.2025.118944_bib63","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-11-4149","article-title":"Novel MT1-MMP small-molecule inhibitors based on insights into hemopexin domain function in tumor growth","volume":"72","author":"Remacle","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118944_bib64","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.1058455","article-title":"Development of anti-membrane type 1-matrix metalloproteinase nanobodies as immunoPET probes for triple negative breast cancer imaging","volume":"9","author":"Mulero","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.biopha.2025.118944_bib66","article-title":"Target engagement of an anti-MT1-MMP antibody for triple-negative breast cancer PET imaging and beta therapy","volume":"136","author":"Magro","year":"2024","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.biopha.2025.118944_bib67","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.4161\/cbt.8.24.10139","article-title":"A novel and selective membrane type-1 matrix metalloproteinase (MT1-MMP) inhibitor reduces cancer cell motility and tumor growth","volume":"8","author":"Suojanen","year":"2009","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.biopha.2025.118944_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1042\/BST20180363","article-title":"MT1-MMP-dependent cell migration: proteolytic and non-proteolytic mechanisms","volume":"47","author":"Gifford","year":"2019","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.biopha.2025.118944_bib69","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","article-title":"Naturally occurring antibodies devoid of light chains","volume":"363","author":"Hamers-Casterman","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.biopha.2025.118944_bib70","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.jconrel.2011.01.032","article-title":"High-affinity peptide against MT1-MMP for in vivo tumor imaging","volume":"150","author":"Zhu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118944_bib71","doi-asserted-by":"crossref","unstructured":"A.-C. Eder, M.A. Omrane, A.R. Regupathy, M.El Fakiri, N. Steinacker, L.-C. Domogalla, C.-F. Wielenberg, M. Mix, J. Lahdenranta, B. Blakeman, Development and clinical translation of a phage display derived MT1-MMP-specific bicyclic peptide for radiotheranostic applications, in: Cancer Res., AMER ASSOC CANCER RESEARCH 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA \u2026, 2025. https:\/\/doi.org\/10.1158\/1538-7445.AM2025-4601.","DOI":"10.1158\/1538-7445.AM2025-4601"},{"key":"10.1016\/j.biopha.2025.118944_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28493-9","article-title":"Optimization of a MT1-MMP-targeting peptide and its application in near-infrared fluorescence tumor imaging","volume":"8","author":"Ren","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118944_bib73","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1021\/acs.bioconjchem.9b00220","article-title":"Screening, identification, and characterization of an affinity peptide specific to mt1-mmp and its application in tumor imaging","volume":"30","author":"Li","year":"2019","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2025.118944_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139471","article-title":"Development of a radiolabeled peptide-based probe targeting MT1-MMP for breast cancer detection","volume":"10","author":"Min","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2025.118944_bib75","doi-asserted-by":"crossref","first-page":"386","DOI":"10.7150\/thno.8006","article-title":"Nanobody: the \u201cmagic bullet\u201d for molecular imaging?","volume":"4","author":"Chakravarty","year":"2014","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2025.118944_bib76","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s40259-019-00392-z","article-title":"The therapeutic potential of nanobodies","volume":"34","author":"Jov\u010devska","year":"2020","journal-title":"BioDrugs"},{"key":"10.1016\/j.biopha.2025.118944_bib77","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s12964-025-02270-4","article-title":"Nanobodies and their derivatives: pioneering the future of cancer immunotherapy","volume":"23","author":"Li","year":"2025","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.biopha.2025.118944_bib78","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3389\/fimmu.2017.01603","article-title":"Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics","volume":"8","author":"Bannas","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118944_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114904","article-title":"Strategies for overcoming protein and peptide instability in biodegradable drug delivery systems","volume":"199","author":"Shi","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118944_bib80","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1186\/s12951-024-02900-y","article-title":"Discovery of nanobodies: a comprehensive review of their applications and potential over the past five years","volume":"22","author":"Alexander","year":"2024","journal-title":"J. Nanobiotechnol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T22:32:09Z","timestamp":1769034729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011382"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":79,"alternative-id":["S0753332225011382"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118944","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the use of MT1-MMP-targeted nanobodies and peptides for therapeutic delivery in triple-negative breast cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118944","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118944"}}